It is of note that an earlier study reported that the PPARγ agonist, pioglitazone improves HFD-induced insulin resistance and steatohepatitis in rodents, whereas body weight is still increased [39]..Consistent with this, our data indicate that mifepristone improves insulin sensitivity without affecting total body weight. This evidence concerns the gene INS and Insulin resistance.